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Abstract
The aim of the study was cytological and immunocytochemical researches of thyrocyte populations in fine-needle as-
piration smears of radioiodine-refractory metastases and their comparison with radioiodine-avid metastases and corresponding 
primary papillary carcinoma of the thyroid. 
Materials and Methods. The cytomorphological and immunocytochemical researches were conducted on the fine needle 
aspiration smears of 60 papillary thyroid carcinomas and 104 metastases, which were detected in the postoperative period. We 
applied the indirect immunoperoxidase technique using primary monoclonal mouse antibodies against leukocyte-common anti-
gen, macrophage antigen, thyroglobulin, epithelial cell adhesion molecule, cytokeratines 7.8, polyclonal rabbit antibodies against 
calcitonin. 
Results. It was demonstrated, that radioiodine-avid metastases and corresponding primary papillary thyroid carcinoma 
smears had first type of cellular population with a relatively regular location of thyrocytes. Unlike them, radioiodine-refractory 
metastases smears had the second type of cellular population with irregularly location of thyrocytes among which showed up two 
cellular phenotypes. In our investigated smears some special cellular complexes were found – in 21 % of radioiodine-refractory 
metastases, 1 % in radioiodine-avid metastases and none of it in corresponding primary papillary thyroid. The cytological sign 
of cystic degeneration was found in 58 % of radioiodine-refractory metastases, but in radioiodine-avid metastases – was absent. 
Conclusion. The radioiodine-refractory metastases of papillary thyroid cancer demonstrated their distinction from radio-
iodine-uptake metastases with a presence of phenotypic heterogeneity. It is shown, that an appearance of certain cell subpopula-
tions, special cellular complexes and cystic degeneration in fine-needle aspiration smears of radioiodine-refractory metastases, 
which in radioiodine-uptake metastases and corresponding primary papillary thyroid carcinomas were not found, can be used 
during the preoperative period to forecast the impossibility of radioiodine treatment. 
Keywords: papillary thyroid carcinoma, fine-needle aspiration punction biopsy, radioiodine-refractory metastases, pheno-
typic heterogeneity of thyrocytes, subpopulations.
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1. Introduction
Applying of radioiodine therapy, which is based on the ability of follicular epithelium to 
accumulate radioiodine (RI), underlies the advantageous prognosis of differentiated thyroid cancer 
(DTC) [1, 2]. Unfortunately, 5–20 % of patients with DTC have metastatic radioiodine-refractory 
disease and the radioiodine therapy become ineffective for them, due to the fact that thyrocytes 
have lost their ability to accumulate radioiodine [3, 4]. Different authors have detected the correla-
tion between a development of radioiodine refractoriness and a significant decrease of the survival 
median [5]. The data regarding a tumors’ resistance to a commonly used therapy has shown that the 
clonal tumor heterogeneity may be based on its development [6, 7]. Both theories of oncogenesis 
(stochastic theory of clonal evolution and cancer stem cell hypothesis) indicate that the monoclonal 
population of malignant tumor cells breaks down into a number of subclones and becomes pheno-
typically heterogeneous because of genetic and epigenetic changes [8, 9]. This may have a clinical 
implication for the disease’s progress and tumor therapy [10]. Cells that have lost their ability to 
accumulate radioiodine can be amongst those subclones that were mentioned. Therefore, the detec-
tion of cellular phenotypes that are associated with radioiodine refractoriness is of current interest 
to examination of the thyrocyte population in radioiodine-refractory metastases (RIRM) of papil-
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lary thyroid carcinoma (PTC). Farther, the available data has no information about subclonal struc-
ture investigation in fine-needle aspiration (FNA) smears. There was a demonstration of population 
heterogeneity in follicular epithelium on the histological sections of the thyroid nodule’s tissue [11]. 
In addition, Mitsutake N. et al have done their in vitro researches of anaplastic thyroid carcinoma’s 
cultures and showed a small subpopulation of cells that have a stem cell attribute [12]. Accordingly, 
the aim of the study was cytological and immunocytochemical researches of thyrocyte populations 
in FNA smears of RIRM and their comparison with radioiodine-avid (RIAM) and corresponding 
primary PTC (PPTC) of the thyroid. 
2. Materials and methods of research
Investigated groups included FNA smears of 60 PTC and 104 metastases that were found 
during the sonographic and scintigraphic examination after thyroidectomy and RI – therapy, i. e. 
postoperative period. The specimens were obtained from patients who were examined, diagnosed 
with tumor and underwent thyroid surgery in the Institute of Endocrinology and Metabolism. The 
patients were both women (120) and man (44), also they were 26–79 years old. 
PTC metastases that were identified by neck sonography after treating patients with 100 mCi 
RI, but not detected by whole body scintigraphy were considered as RI-refractory (RIRM) ones. 
In contrast, PTC metastases that were found by scintigraphy after similar treatment were regarded 
as RI-avid (RIAM) ones. We have analyzed FNA smears of 79 RI-refractory and 25 RI-avid PTC 
metastases. FNA of thyroid and metastases was performed under ultrasound guidance using a 
21-gauge needle, usually without a syringe or suction. Dried FNA smears were fixed for 5 minutes 
in methanol, followed by staining in Giemsa dye, diluted in 0.067M phosphate buffer (pH 6.4) for 
30 minutes. 
Immunocytochemistry was performed on representative Giemsa-stained smears after 
they were analyzed cytomorphologically. We’ve developed a method, which helps to unmasked 
antigens [13]. To identify certain antigens, we applied the indirect immunoperoxidase technique 
using primary monoclonal mouse antibodies against leukocyte-common antigen (CD45) (dilu-
tion 1:50, clone PD7/26 and 2B11, Dako, Denmark), macrophage antigen (CD68) (dilution 1:50, 
clone EBM11, Dako, Denmark), thyroglobulin (Tg) (dilution 1:100, clone DAK-Tg6, Dako, Den-
mark), epithelial cell adhesion molecule (epCAM) (dilution 1:100, clone Ber-Ep4, Dako, Den-
mark) as well as a number of cytokeratines (CK), namely CK7 (dilution 1:50, clone OV-TL 12/30, 
Dako, Denmark), CK8 (dilution 1:100; clone M20, Sigma, USA). Polyclonal rabbit antibodies 
were used to identify calcitonin (dilution 1:100, DBS, USA). Polyclonal rabbit anti-mouse im-
munoglobulins/HRP (dilution 1:100, Dako, Denmark) and goat anti-rabbit immunoglobulins/
HRP (dilution 1:100, Dako, Denmark) were applied as enzyme-labeled secondary antibodies. 
3,3-diaminobenzidine tetrahydrochloride (Sigma, USA) was used as a chromogen. Endogenous 
peroxidase was inactivated by incubation in 1 % H2O2 in phosphate buffer (pH 7.4) at the room 
temperature for 30 minutes. Statistic analysis was performed via the non-parametric criterion χ2 
in the package Statistica 11.0.
3. Results and discussion
The comparative cytological and immunocytochemical research of thyrocyte popu-
lations on smears of RIRM, RIAM and corresponding PPTC demonstrated the phenotypic 
heterogeneity in RIRM epithelium and its absence in the rest of the groups. RIAM and cor-
responding PPTC smears had the first type of cellular population, which comprised small ep-
ithelial cells (12–20 microns) with moderate nuclear-cytoplasmic ratios that had amphophilic 
or faintly oxyphilic cytoplasm. Also, they formed a single-layered formation with a relatively 
regular location of thyrocytes (Fig. 1).
Such thyrocytes featured the bright antibody reactions – cytokeratin 7 and 8, thyroglobulin, 
epithelial cell adhesion molecules (epCAM) (Fig. 2).
However, RIRM smears had the second type of cellular population, which comprised en-
larged polymorphic basophilic cells (24–48 microns) that had a reduced nuclear-cytoplasmic ratio. 
Thyrocytes were located irregularly among this type of cells (Fig. 3).
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Fig. 1. The first type of cellular population with regular location of homogeneous, small 
thyrocytes in FNA smear of RIAM. ×400
Fig. 2. Intensive immunocytochemical reactions with antibodies to thyroglobulin on each 
thyrocyte in FNA smear of RIAM of PTC. ×200
Fig. 3. The second type of cellular population with irregular location of polymorphic thyrocytes 
in FNA smear of RIRM of PTC. ×400
The immunocytochemical reaction with antibodies to thyroglobulin had a mosaic appear-
ance on these cellular populations (Fig. 4).
Fig. 4. A mosaic immunocytochemical reaction with antibodies to thyroglobulin on thyrocytes in 
FNA smear of RIRM of PTC. ×200
Among the second type of cellular population showed up two cellular phenotypes. The 
first phenotype differentiated with their surface condition, clear-cut edges, round or pear shape, 
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small nuclear-cytoplasmic ratio and diversified proportions (18–40 microns). Their cytoplasm had 
a moderate basophilia in a central area and had no stain on the periphery, thus they looked lighter 
among the other epithelial cells. Contingently, we called them cells of “S” subpopulation (Fig. 5).
a                                                                 b
Fig. 5. “S” cells in FNA smear of RIRM of PTC: a – “S” cell with clear-cut edges;  
b – “S” cells among other thyrocytes. ×400
The immunocytochemical investigations have shown that “S” cells do not comprise a leuko-
cyte common antigen (CD45) and a macrophage marker (CD68), despite their resemblance to mac-
rophages. Their positive antibody reaction to cytokeratins 7 and 8 instantiates an epithelial nature. 
“S” cells between times bind antibodies against cytokeratin 17, expression of which constantly oc-
curs in PTC [14]. Meanwhile, “S” cells do not react with antibodies against epCAM, notwithstand-
ing, this antigen always belong to all the epithelial thyrocytes (as a normal and with malignancy). 
Furthermore, “S” cells did not give a precise reaction to antibodies against thyroglobulin and did 
not comprise calcitonin, which excludes their relation to parafollicular cells.
A distinctive feature of the second phenotype was a round basophilic macula (diameter – 
4.5–18 μm) in the cytoplasm near the nucleus. After the RNase influence, this macula did not 
stain with azure, which testifies that it consists of RNA. Contingently, we called them cells of “M” 
subpopulation. In contradistinction to “S” cells, they did not have clear-cut edges, insofar as their 
surface did not differ from other thyrocytes in expressive refraction (Fig. 6).
Fig. 6. “M” cell (macula-containing cell) in FNA smear of RIRM of PTC. ×400
The immunocytochemical investigations have shown that “M” cells do not comprise CD45 
and CD68 and have positive reaction with antibodies to cytokeratins 7 and 8, which justify their 
epithelial nature. As well as “S” cells, “M” cells do not have calcitonin. However, unlike “S” 
cells, “M” cells have thyroglobulin. Their antibody reaction against epCAM differs from other 
thyrocytes – expression is absent or has a temper by the way of the laminar structure between the 
contacting surfaces of “M” cells.
“S” cells were found in 31 %, “M” cells – in 30 % of the investigated RIRM PTC and were 
absent in all investigated RIAM. “M” cells were found in 35 % of corresponding PPTC, but “S” 
cells were absent there.
Moreover, some special cellular complexes were found in our investigated smears – in 21 % 
of RIRM, 1 % in RIAM and none of it in corresponding PPTC (Fig. 7). 
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 Fig. 7. Special complex of psammous body and vacuolated cells in  
FNA smear of RIRM of PTC. ×400
These complexes consist of centrally located psammous body, surrounded by a layer of mac-
rophages and vacuolated epithelial cells, most of which have cytokeratin 17. We have demonstrated 
that this cytokeratin represents as a preoperative marker for radioiodine refractoriness of thyroid 
cancer [14].
The cytological sign of cystic degeneration (cystic fluid with macrophages) was found in 58 % 
of RIRM, but in RIAM – was absent. In overall group of metastases of PTC, cystic degeneration 
was revealed only in 23 % of cases.
In this way, the comparative cytological and immunocytochemical researches in the thyro-
cyte population structure of RIRM, RIAM and corresponding PPTC have demonstrated the pheno-
typic heterogeneity in RIRM, which appeared in the form of various cellular phenotypes, specific 
cellular complexes and cystic degeneration (Table 1).
Таble 1
The frequency of various cytological signs in FNA smears of RIRM and RIAM PTC
Cytological signs RIRM (79) RIАM (25)
The first type of cellular population 50(79) 63.2 % 100 %
The second type of cellular population 37(79) 46.8 % 0 %
“S”-cells 25(79) 31 %* 0 %
“M”-cells 24(79) 30 %* 0 %
“S”+“M”-cells 8(79) 10 % 0 %
Cystic degeneration 35(79) 44 %* 1(25) 1 %
Complexes of psammous body and thyrocytes 17(79) 21 %* 0 %
Cellular oxifilia 10(79) 12.6 % 1(25) 1 %
Note: * – p<0.05
The presence of different subclones and thyrocyte complexes in FNA smears of RIRM 
PTC in comparison with RIUM, perhaps, is a demonstration of their genetic heterogeneity, which 
is a “firing field” for appearance of thyrocyte subclones that can predetermine the progress of ra-
dioiodine refractoriness. The immunocytochemical researches demonstrated that “S” cells have 
no thyroglobulin, which is relevant to the radioiodine accumulation. Besides, “S” and “M” cells 
have off-balanced expression and spreading of epCAM on the cytoplasmic surface. As known, 
these molecules are considered to be one of the crucial factors in epithelial-mуsenchymal transi-
tion when epithelial cells lose their polarity, intercellular adhesion and attain the migration ability 
[15]. Perhaps, these characteristics of the cellular phenotype in explored metastases are a source of 
radioiodine refractoriness. 
The study of cellular phenotypes in epithelium of PTC and its metastases is a latter-day 
cytological approach, not particularly their cytological and immunocytochemical signs. This ap-
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proach allows scrutinizing the correlation between radioiodine refractoriness and aggressive be-
havior of PTC with not only individual cellular characteristics, but with the complex of cytological 
and immunocytochemical characteristics that are associated with different cellular subpopulation 
(or phenotypes).
Since the phenotypic heterogeneity of thyrocyte population (presence of different subpop-
ulations and cellular complexes) as a cytological characterstic is found in smears of RIRM PTC 
and not in RIAM, thereat its appearance can be considered as a cytological factor in radioiodine 
refractoriness prognosis for postoperative metastases of PTC. So, thanks to conducted researches it 
is possible to predict during preoperative period the behavior of metastases that were detected after 
thyroidectomy and radioiodine therapy and to determine an adequate tactic of treatment (further 
radioiodine therapy or surgical removal of metastases). 
4. Conclusions
1. The subclonal structure in the population of metastases of PTC that were found during the 
postoperative period (RIRM and RIAM), for the first time ever, was investigated on FNA smears 
with cytomorphological and immunocytochemical researches.
2. It was demonstrated, that RIRM PTC differs from RIAM in phenotypic heterogeneity. It 
has been proved, that an appearance of certain cellular subpopulation, which are absent in PPTC 
and RIUM, but occur in RIRM, can be used for the preoperative prognosis of refractoriness to 
radioiodine therapy.
3. The phenotypic heterogeneity research in thyrocyte population of PTC is a latter-day and 
effective route in developing the methods of prognosis for metastases that has radioiodine refrac-
toriness.
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Abstract
The present work studied the effect of aqueous extract from Feijoa leaves on thyroid function of rats with experimental 
hypothyroidism. Healthy albino rats weighing between 120 g and 150 g were used. The animals were randomly allotted into four 
groups, each containing eight rats respectively. Three of the groups (II, III and IV), induced with hypothyroidism, were treated 
by 0.05 % solution of thiamazole with drinking water for 30 days. Control (vehicle) rats were given normal saline. After 13 days 
hypothyroid groups (III and IV) of rats were treated with aqueous extract from Feijoa leaves at a dose 1.0 ml/100 g of body weight 
and with Iodomarin 200 (reference drug) at a dose 12 µg/kg daily orally for 21 days. Results obtained from the study showed that 
the introduction of thiamazole leads to functional changes in the thyroid gland in rats, accompanied by decreasing sings of rectal 
temperature and level of thyroid hormones. It was found, that treatment with AEFL normalizes serum thyroid hormone levels, in-
creases rectal temperature and reduces the thyroid mass. The investigated extract can be attributed to the regulators of the thyroid 
hypofunction and is promising for further study of its effectiveness as a thyroid-stimulating agent. 
Keywords: Feijoa leaves, aqueous extract, hypothyroidism, thiamazole, thyroid hormones.
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